Meyka AI API is live for developers.Start building.
Advertisement
Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc. (CEMI) Stock Overview

Explore Chembio Diagnostics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CEMI●NASDAQ
HealthcareMedical - Diagnostics & Research
$0.46
$0.001(0.22%)
U.S. Market opens in 52h 42m
Advertisement

Chembio Diagnostics, Inc. (CEMI)

Meyka AI Score

Z

Key Financials

Market Cap16.7M
P/E Ratio-0.47
EPS (TTM)$-0.72
ROE-0.89%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

CEMI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Chembio Diagnostics, Inc. (CEMI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.47 and a market capitalization of 16.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
1.56%
6-Month Change
42.41%
Year-to-Date (YTD) Change
80.20%
1-Year Change
-32.55%
3-Year Change
-95.35%
5-Year Change
-95.24%
All-Time (Max) Change
-99.98%

Contact Information

https://chembio.com
631 924 1135
555 Wireless Boulevard, Hauppauge, NY, 11788

Company Facts

1,880 Employees
IPO DateOct 18, 2000
CountryUS

Frequently Asked Questions